Marc Scherlinger

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Disease Activity

Respiratory Syndrome Coronavirus

Systemic Lupus Erythematosus

Top Venues

Annals of the rheumatic diseases

Nature reviews. Immunology

Nature communications

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Marc Scherlinger, Hao Li, Wenliang Pan, Wei Li, Kohei Karino, Theodoros Vichos, Afroditi Boulougoura, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature communications 15 (1) (2024)
Marc Scherlinger, Hao Li, Wenliang Pan, Wei Li, Kohei Karino, Theodoros Vichos, Afroditi Boulougoura, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature communications 15 (1) (2024)
Marc Scherlinger, Hao Li, Wenliang Pan, Wei Li, Kohei Karino, Theodoros Vichos, Afroditi Boulougoura, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature communications 15 (1) (2024)
Marc Scherlinger, Hao Li, Wenliang Pan, Wei Li, Kohei Karino, Theodoros Vichos, Afroditi Boulougoura, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature communications 15 (1) (2024)
Marc Scherlinger, Hao Li, Wenliang Pan, Wei Li, Kohei Karino, Theodoros Vichos, Afroditi Boulougoura, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nature communications 15 (1) (2024)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
Author Correction: The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Marc Scherlinger, Christophe Richez, George C Tsokos, Éric Boilard, Patrick Blanco
The role of platelets in immune-mediated inflammatory diseases. Nature reviews. Immunology (2023)
Wenliang Pan, Marc Scherlinger, Nobuya Yoshida, Maria G Tsokos, George C Tsokos
PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma. Journal of immunology (Baltimore, Md. : 1950) 209 (3) (2022)
Marc Scherlinger, Naimah Zein, Jacques-Eric Gottenberg, Marianne Rivière, Jean-François Kleinmann, Jean Sibilia, Laurent Arnaud
Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus: A Nationwide Patient Association Study. Healthcare (Basel, Switzerland) 10 (2) (2022)
Marc Scherlinger, Cédric Lemogne, Renaud Felten, Jean Sibilia
Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic. Infectious diseases and therapy 11 (6) (2022)
Marc Scherlinger, Wenliang Pan, Ryo Hisada, Afroditi Boulougoura, Nobuya Yoshida, Milena Vukelic, Masataka Umeda, Suzanne Krishfield, Maria G Tsokos, George C Tsokos
Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Science advances 8 (48) (2022)
Marc Scherlinger, Renaud Felten, Floriane Gallais, Charlotte Nazon, Emmanuel Chatelus, Luc Pijnenburg, Amaury Mengin, Adrien Gras, Pierre Vidailhet, Rachel Arnould-Michel, Sabrina Bibi-Triki, Raphaël Carapito, Sophie Trouillet-Assant, Magali Perret, Alexandre Belot, Seiamak Bahram, Laurent Arnaud, Jacques-Eric Gottenberg, Samira Fafi-Kremer, Jean Sibilia
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection. Infectious diseases and therapy 10 (3) (2021)
Marc Scherlinger, George C Tsokos
Shortage of aspartate in mitochondria fuels arthritis. Nature immunology 22 (12) (2021)
Marc Scherlinger, Vivien Guillotin, Isabelle Douchet, Pierre Vacher, Andréa Boizard-Moracchini, Jean-Philippe Guegan, Anne Garreau, Nathalie Merillon, Agathe Vermorel, Emmanuel Ribeiro, Irène Machelart, Estibaliz Lazaro, Lionel Couzi, Pierre Duffau, Thomas Barnetche, Jean-Luc Pellegrin, Jean-François Viallard, Maya Saleh, Thierry Schaeverbeke, Patrick Legembre, Marie-Elise Truchetet, Hélène Dumortier, Cécile Contin-Bordes, Vanja Sisirak, Christophe Richez, Patrick Blanco
Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Science translational medicine 13 (600) (2021)
Marc Scherlinger, Thierry Schaeverbeke
Correspondence on 'Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting'. Annals of the rheumatic diseases (2021)
Marc Scherlinger, Luc Pijnenburg, Emmanuel Chatelus, Laurent Arnaud, Jacques-Eric Gottenberg, Jean Sibilia, Renaud Felten
Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study. Vaccines 10 (1) (2021)
Marc Scherlinger, Thierry Schaeverbeke
'To switch or not to switch': the missing piece in the puzzle of biosimilar literature? Annals of the rheumatic diseases 79 (4) (2019)
Marc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, Thomas Barnetche, Pierre Duffau, Lionel Couzi, Julien Seneschal, Patrick Blanco, Estibaliz Lazaro, Christophe Richez
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study. Annals of the rheumatic diseases 78 (7) (2019)
Marc Scherlinger, Thierry Schaeverbeke
Additional response to the correspondence: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Bennuci. Annals of the rheumatic diseases 78 (4) (2018)
Marc Scherlinger, Thierry Schaeverbeke
Response to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Benucci. Annals of the rheumatic diseases 78 (4) (2018)
Vincent Germain, Marc Scherlinger, Thomas Barnetche, Thierry Schaeverbeke, null null
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect. Annals of the rheumatic diseases 79 (1) (2018)